Due to the triad of microangiopathic hemolysis, thrombocytopenia, and organ damage, we proposed the diagnostic hypothesis of TMA (ADAMTS-13 dosage was not available in our hospital at that time), and we started fresh frozen plasma replacing (10 mL/Kg, twice a day) with subsequent plasmapheresis. Here, ADAMTS13 is linked to Thrombocytopenia.